Acute myeloid leukemia (AML) is a malignant clonal disease derived from hematopoietic stem/progenitor cell. Leukemia blasts cause extensive hypoxia of bone marrow (BM), which lead to disorder and remodeling of BM niche, thereby becoming “leukemic niche” to support the development and drug-resistance of AML as well as the maintenance of normal hematopoietic stem cells. In this study, the biological characteristics (such as self-renewal, apoptosis, migration, autocrine) and function (vascularization) of mesenchymal stem cells (MSCs) and human umbilical artery endothelial cells (HUAECs) that make up BM arteriolar niche in simulated hypoxia AML context were investigated. It was found that moderate hypoxia enhanced the viability of the arteriolar niche cells, but severe hypoxia of AML BM resulted in the damage of arteriolar niche cells and the disorder of vascular cytokines C-X-C motif chemokine ligand 6 (CXCL6). The dynamic changes of CXCL6 in the system as well as its anti-apoptotic and promoting angiogenic effects suggested that CXCL6 played an important role in the remodeling of BM arteriolar niche in AML. Taking advantage of CXCL6 can save the damaged MSCs and HUAECs, which is the hope of rescuing arteriolar niche. It is suggested that CXCL6 may be an assistant strategy for microenvironment targeted therapy of AML.
MillerKDNogueiraLMariottoABRowlandJHYabroffKRAlfanoCMJemalAKramerJLSiegelRL.Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin2019;
69:363–85
2.
BernasconiPFarinaMBoniMDambruosoICalvelloC.Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: a worthy endeavor?.Am J Hematol2016;
91:507–17
3.
Nombela-ArrietaCSilbersteinLE.The science behind the hypoxic niche of hematopoietic stem and progenitors. Hematol Am Soc Hematol Educ Prog2014;
2014:542–7
4.
SpencerJAFerraroFRoussakisEKleinAWuJRunnelsJMZaherWMortensenLJAltCTurcotteRYusufRCoteDVinogradovSAScaddenDTLinCP.Direct measurement of local oxygen concentration in the bone marrow of live animals. Nature2014;
508:269–73
HanounMZhangDMizoguchiTPinhoSPierceHKunisakiYLacombeJArmstrongSADührsenUFrenettePS.Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche. Cell Stem Cell2014;
15:365–75
7.
KwonSYChunSYHaY-SKimDHKimJSongPHKimHTYooESKimBSKwonTG.Hypoxia enhances cell properties of human mesenchymal stem cells. Tissue Eng Regen Med2017;
14:595–604
8.
DuarteDHawkinsEDAkinduroOAngHDe FilippoKKongIYHaltalliMRuivoNStraszkowskiLVervoortSJMcLeanCWeberTSKhorshedRPirilloCWeiARamasamySKKusumbeAPDuffyKAdamsRHPurtonLECarlinLMLo CelsoC.Inhibition of endosteal vascular niche remodeling rescues hematopoietic stem cell loss in AML. Cell Stem Cell2018;
22:64–77.e6
9.
PassaroDBonnetD.How to say NO to vascular disruption and stem cell mobilization. Expert Opin Ther Targets2018;
22:563–5
10.
LavrentievaAMajoreIKasperCHassR.Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells. Cell Commun Signal2010;
8:18
11.
MaJ-CSunX-WSuHChenQGuoT-KLiYChenX-CGuoJGongZ-QZhaoX-DQiJ-B.Fibroblast-derived CXCL12/SDF-1α promotes CXCL6 secretion and co-operatively enhances metastatic potential through the PI3K/Akt/mTOR pathway in colon cancer. World J Gastroenterol2017;
23:5167–78
12.
PassaroDDi TullioAAbarrategiARouault-PierreKFosterKAriza-McNaughtonLMontanerBChakravartyPBhawLDianaGLassaillyFGribbenJBonnetD.Increased vascular permeability in the bone marrow microenvironment contributes to disease progression and drug response in acute myeloid leukemia. Cancer Cell2017;
32:324–41 e326
13.
TynerJWTognonCEBottomlyDWilmotBKurtzSESavageSLLongNSchultzARTraerEAbelMAgarwalABlucherABorateUBryantJBurkeRCarlosACarpenterRCarrollJChangBHCoblentzCd’AlmeidaACookRDanilovADaoK-HTDegninMDevineDDibbJEdwardsDKEideCAEnglishIGloverJHensonRHoHJemalAJohnsonKJohnsonRJunioBKaempfALeonardJLinCLiuSQLoPLoriauxMMLutySMaceyTMacManimanJMartinezJMoriMNelsonDNicholsCPetersJRamsdillJRofeltyASchuffRSearlesRSegerdellESmithRLSpurgeonSESweeneyTThapaAVisserCWagnerJWatanabe-SmithKWerthKWolfJWhiteLYatesAZhangHCogleCRCollinsRHConnollyDCDeiningerMWDrusboskyLHouriganCSJordanCTKropfPLinTLMartinezMEMedeirosBCPallapatiRRPollyeaDASwordsRTWattsJMWeirSJWiestDLWintersRMMcWeeneySKDrukerBJ.Functional genomic landscape of acute myeloid leukaemia. Nature2018;
562:526–31
14.
EllinghausPHeislerIUnterschemmannKHaerterMBeckHGreschatSEhrmannASummerHFlammeIOehmeFThierauchKMichelsMHess-StumppHZiegelbauerK.Bay 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I. Cancer Med2013;
2:611–624
15.
SaxtonRASabatiniDM.mTOR signaling in growth, metabolism, and disease. Cell2017;
168:960–76
16.
SchitoLReyS.Cell-Autonomous metabolic reprogramming in hypoxia. Trends Cell Biol2018;
28:128–42
17.
JensenPOMortensenBTHodgkissRJIversenPOChristensenIJHelledieNLarsenJK.Increased cellular hypoxia and reduced proliferation of both normal and leukaemic cells during progression of acute myeloid leukaemia in rats. Cell Prolif2000;
33:381–95
18.
BaldeaITeacoeIOlteanuDEVaida-VoievodCClichiciASirbuAFilipGAClichiciS.Effects of different hypoxia degrees on endothelial cell cultures – time course study. Mech Ageing Dev2018;
172:45–50
19.
MelzerCYangYHassR.Interaction of MSC with tumor cells. Cell Commun Signal2016;
14:20
20.
GeQZhangHHouJWanLChengWWangXDongDChenCXiaJGuoJChenXWuX.VEGF secreted by mesenchymal stem cells mediates the differentiation of endothelial progenitor cells into endothelial cells via paracrine mechanisms. Mol Med Rep2018;
17:1667–75
21.
PoulosMGGarsEJGutkinMCKlossCCGinsbergMScanduraJMRafiiSButlerJM.Activation of the vascular niche supports leukemic progression and resistance to chemotherapy. Exp Hematol2014;
42:976–86 e973
22.
DuarteDHawkinsEDLo CelsoC.The interplay of leukemia cells and the bone marrow microenvironment. Blood2018;
131:1507–11
23.
ChoudhryHHarrisAL.Advances in hypoxia-Inducible factor biology. Cell Metab2018;
27:281–98
24.
RankinEBGiacciaAJ.Hypoxic control of metastasis. Science2016;
352:175–80
25.
MengDFrankARJewellJL.mTOR signaling in stem and progenitor cells. Development2018;
145:dev152595
26.
BernasconiPBorsaniO.Targeting leukemia stem cell-niche dynamics: a new challenge in AML treatment. J Oncol2019;
2019:8323592
